Fund profile by ISIN IE000B9PQW54
VanEck Genomics and Healthcare Innovators UCITS ETF
Research VanEck Genomics and Healthcare Innovators UCITS ETF by ISIN IE000B9PQW54: TER 0.35%, domicile Ireland, and 1-year price performance +30.3%.
ISINIE000B9PQW54
TER0.35%
DomicileIreland
Distribution policy—
Index—
Fund size14M
Holdings—
1-year price performance+30.3%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| CURG.L | LSE | GBP | Ireland | €110K | 6,090 |
| CURE.DE | XETRADefault at German brokers | EUR | Ireland | €70K | 3,399 |
| CURE.L | LSE | USD | Ireland | €54K | 3,056 |
| CURE.MI | ETFP | EUR | Ireland | €17K | 852 |
| CURE.SW | SW | CHF | Ireland | €5K | 251 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-08-28.
Largest holdings
The 10 largest holdings make up 60.81% of the fund. As of 2026-08-14.
| Holding | Symbol | Weight |
|---|---|---|
| Regeneron Pharmaceuticals Inc | REGN | 9.12% |
| Vertex Pharmaceuticals Inc | VRTX | 7.88% |
| Natera Inc | NTRA | 7.23% |
| DexCom Inc | DXCM | 7.02% |
| Veeva Systems Inc Class A | VEEV | 6.71% |
| Illumina Inc | ILMN | 5.67% |
| Guardant Health Inc | GH | 5.01% |
| Moderna Inc | MRNA | 4.82% |
| BioNTech SE ADR | BNTX | 3.85% |
| Alnylam Pharmaceuticals Inc | ALNY | 3.49% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.